Home | Publications | Research (R&D) | Clinical Trials place holder
place holder place holder

Clinical Trials

Clinical Immunoanalyzer Markets


Publication Date   December 2007
Publisher   TriMark Publications
Product Type   Report
Pages   156
ISBN Number   TMRCIA06-1106
Product Code   TRI060
Ask a question about this product?

Price £1,690.00

approximately: $2,984 | €2,143

Summary


Clinical immunoanalyzer analysis is one of the most important functions of clinical laboratory analysis. By all accounts, automated immunoassay testing is the most rapidly developing of the traditional clinical laboratory sectors. Clinical immunoanalyzer analysis usually refers to determining the concentration or activity of protein, carbohydrate, lipid, enzyme or small molecule in easily collected body fluids, such as blood, serum, plasma or urine. However, it is not necessarily limited to these purposes. The analysis of virtually any biologically active substance in any place in the body can generally be defined as clinical immunoassay testing. In fact, traditional specialization barriers, such as microbiology, hematology, blood banking, immunology and even anatomical pathology are fading rapidly, both operationally and instrumentally. This TriMark Publications report deals with the traditional scope of clinical immunoassay, while looking at the emerging technology trends in this sector. The purpose of this study is to describe the specific segments of the global clinical immunoanalyzer instrumentation market. Within this area, the highly-active segments in terms of innovation and growth are covered. Specifically, it examines the markets for small labs and highly-automated large lab platforms, as well as the market for accessory equipment, such as reagents and supplies. Emphasis is on those companies and products that are actively developing and marketing immunoanalyzer products for clinical setting, including hospitals, independent labs, physician's offices and clinics.

Content


  • 1. Overview
    • 1.1 Objectives
    • 1.2 Methodology
    • 1.3 Trimark Publications Report Research And Data Acquisition Structure
    • 1.4 Scope
    • 1.5 Executive Summary
  • 2. Ivd Clinical Immunoanalyzer Market
    • 2.1 Introduction
  • 3. Ivd Clinical Immunoanalyzer Market Analysis
    • 3.1 Markets
      • 3.1.1 Global Markets
      • 3.1.2 Global Drivers Of Clinical Immunoanalyzer Testing
      • 3.1.3 Global Outlook
      • 3.1.4 U.S. Market
      • 3.1.5 European Ivd Market
        • 3.1.5.1 German Clinical Immunoanalyzer Diagnostic Markets
        • 3.1.5.2 U.K. Clinical Immunoanalyzer Testing Diagnostic Market
        • 3.1.5.3 French Clinical Laboratory Diagnostic Testing Market
        • 3.1.5.4 Italian Clinical Immunochemistry Diagnostic Market
        • 3.1.5.5 Spanish Immunoanalyzer Market
        • 3.1.5.6 Finnish Immunoanalyzer Market
        • 3.1.5.7 Belgian Immunoanalyzer Market
        • 3.1.5.8 Swiss Immunoanalyzer Market
        • 3.1.5.9 Dutch Immunoanalyzer Market
        • 3.1.5.10 Portugese Immunoanalyzer Market
        • 3.1.5.11 Austrian Immunoanalyzer Market
        • 3.1.5.12 Greek Immunoanalyzer Market
        • 3.1.5.13 Polish Immunoanalyzer Market
        • 3.1.5.14 Romanian Immunoanalyzer Market
      • 3.1.6 Indian Clinical Analyzer Diagnostic Market
        • 3.1.6.1 India's In Vitro Diagnostic Testing Industry
      • 3.1.7 Japanese Clinical Immunoanalyzer Testing Market
      • 3.1.8 Country Clinical Analyzer Smaller Markets
        • 3.1.8.1 China Clinical Analyzer Market
        • 3.1.8.2 Canada Clinical Analyzer Market
        • 3.1.8.3 Brazil Clinical Analyzer Market
        • 3.1.8.4 Turkey Clinical Immunoanalyzer Market
        • 3.1.8.5 Australia Clinical Analyzer Market
        • 3.1.8.6 Rest Of The World Clinical Analyzer Testing Market
      • 3.1.9 Overview Of Asian Healthcare Market
        • 3.1.9.1 Singapore
        • 3.1.9.2 Malaysia
        • 3.1.9.3 Thailand
        • 3.1.9.4 Indonesia
        • 3.1.9.5 Philippines
        • 3.1.9.6 South Korea
        • 3.1.9.7 India
        • 3.1.9.8 Hong Kong
        • 3.1.9.9 Taiwan
    • 3.2 Clinical Immunoanalyzer Sector
      • 3.2.1 Industry-Served Markets
      • 3.2.2 Industry Players
        • 3.2.2.1 Manufacturing Companies
      • 3.2.3 Market Specialization
      • 3.2.4 Revenue And Reimbursement
      • 3.2.5 Companies
    • 3.3 Outlook For Clinical Immunoanalyzer Testing
      • 3.3.1 Long-Term Changes
      • 3.3.2 Market Drivers
      • 3.3.3 Limits To Growth
      • 3.3.4 Hot Sectors In Ivd Market
      • 3.3.5 Key Technologies
      • 3.3.6 Analyzer Integration Chemistry/Immunoassay
      • 3.3.7 Conclusion
  • 4. Clinical Immunoanalyzer Instrument Market By Sector
    • 4.1 Market Analysis: Size, Growth, Share And Competitors
      • 4.1.1 Immunochemistry Analyzers
      • 4.1.2 Large-Volume Immunochemistry Analyzers
        • 4.1.2.1 Abbott Diagnostics
        • 4.1.2.2 Siemens Medical Solutions Diagnostics
        • 4.1.2.3 Beckman Coulter
        • 4.1.2.4 Dade Behring (Siemens)
        • 4.1.2.5 Diagnostics Products Corporation (Siemens)
        • 4.1.2.6 Olympus
        • 4.1.2.7 Ortho-Clinical Diagnostics
        • 4.1.2.8 Roche Diagnostics
        • 4.1.2.9 Tosoh Bioscience
      • 4.1.3 Batch-Type Immunoassay Analyzers
        • 4.1.3.1 Bio-Rad
        • 4.1.3.2 Dade Behring
        • 4.1.3.3 Diamedix
        • 4.1.3.4 Tosoh
      • 4.1.4 Small-Volume To Mid-Volume Immunoassay Analyzers
        • 4.1.4.1 Awareness Technology
        • 4.1.4.2 Siemens Diagnostics
        • 4.1.4.3 Beckman Coulter
        • 4.1.4.4 Biomrieux
        • 4.1.4.5 Dade Behring (Siemens)
        • 4.1.4.6 Randox
        • 4.1.4.6.1 Randox Laboratories
        • 4.1.4.7 Tosoh
      • 4.1.5 Other Immunoassay Analyzers
        • 4.1.5.1 Inverness Medical Professional Diagnostics
        • 4.1.5.2 Hycor Biomedical
        • 4.1.5.3 Phadia
        • 4.1.5.4 Trinity Biotech
        • 4.1.5.5 Diasorin
        • 4.1.5.6 Grifols
        • 4.1.5.7 Bio-Rad
        • 4.1.5.8 Sfri Diagnostics
        • 4.1.5.9 Qualigen
        • 4.1.5.10 Perkinelmer Life And Analytical Sciences
        • 4.1.5.11 Innotrac Diagnostics
        • 4.1.5.12 Tecan
  • 5. Important Technology Trends
    • 5.1 Technology Innovations In Immunoassay Testing
    • 5.2 Immunoassay Detection Technology Platforms
      • 5.2.1 Fluorescence Detection
      • 5.2.2 Chemiluminescence Detection
    • 5.3 The New Paradigm
    • 5.4 Consolidated Workstations
    • 5.5 Automation In The Laboratory In Response To Labor Shortages
    • 5.6 Laboratory Information System (Lis)
    • 5.7 Biosensor Technology
    • 5.8 Data Management Issues
      • 5.8.1 Wireless Lans
      • 5.8.2 Data And Workflow Management Systems
      • 5.8.3 Beckman Central Command
      • 5.8.4 Advances In Information Management
      • 5.8.5 Connectivity Platforms
      • 5.8.6 Datalink Data Management System
      • 5.8.7 Labportal.Com
      • 5.8.8 Lifescan Electronic Data Interfaces
      • 5.8.9 Technical Problems Of Connectivity
      • 5.8.10 Web-Based Data Interface And Internet Connectivity
      • 5.8.11 Hit Competition
      • 5.8.12 Fda-Required Software Verification
      • 5.8.13 Advantages Of Connectivity
      • 5.8.14 Technologies For Internet-Based Remote Architecture
      • 5.8.15 Abbott Multitiered Internet System
  • 6. Business Trends In Clinical Immunoanalyzer Sector
    • 6.1 Key Developments
    • 6.2 Sector Consolidation
    • 6.3 Diagnostic Testing Growth Trends
    • 6.4 Reagents And Hardware Business In Japan
    • 6.5 New Products
    • 6.6 Acquisitions, License Agreements, Internal Developments And Partnerships
    • 6.7 Product Testing Depth In Clinical Immunoanalyzer Testing
    • 6.8 Government Regulations
      • 6.8.1 U.S. Government Regulations
        • 6.8.1.1 Importing Medical Devices Into The U.S.
        • 6.8.1.2 Exporting Medical Devices From The U.S.
      • 6.8.2 U.K. Regulations
      • 6.8.3 E.U. Regulations
      • 6.8.4 Japanese Regulations
      • 6.8.5 Korean Regulations
    • 6.9 Increased Market Penetration
    • 6.10 Costs Of Doing Business In Europe
    • 6.11 Drivers Of European Diagnostics Testing
    • 6.12 European Reimbursement Practices
    • 6.13 Cost Containment In Europe
    • 6.14 Medicare Spending Trends/Medicare Part B Spending Trends
  • 7. Company Profiles
    • 7.1 Abbott Diagnostics
    • 7.2 Bayer Healthcare
    • 7.3 Beckman Coulter
    • 7.4 Biomrieux
    • 7.5 Dade Behring
    • 7.6 Bio-Rad Laboratories
    • 7.7 Olympus
    • 7.8 Ortho-Clinical Diagnostics
    • 7.9 Phadia
    • 7.10 Randox Laboratories
    • 7.11 Roche Diagnostics
    • 7.12 Tosoh
    • 7.13 Siemens
  • 8. Clinical Immunoanalyzer Testing Sector: Trends And Forecasts
    • 8.1 Automated Intrument Platforms Evolution
    • 8.2 Reagents And Supplies Market For Clinical Lab Instruments
    • 8.3 Bar Code Reading
    • 8.4 Measurement And Detection For Immunoassay Analyzers
    • 8.5 Robotics
    • 8.6 Move Away From Central Laboratory
    • 8.7 Modular Automation
    • 8.8 Components Of Immunoassay Analyzers
    • 8.9 Drivers Of Clinical Immunoanalyzer Testing
    • 8.10 Confluence Of New Technology
    • 8.11 New Trends In Clinical Laboratory Testing
      • 8.11.1 Trends In Reimbursement Practices
      • 8.11.2 Managed Care
      • 8.11.3 Changes In Patient Management
      • 8.11.4 Focused Testing
      • 8.11.5 Spending For Clinical Laboratory Testing
      • 8.11.6 Reimbursement Pressure
      • 8.11.7 Multiplexing Technology
  • 9. Product Launches
    • 9.1 Immunoassay Analyzer Product Launches
    • 9.2 Immunoassay Reagent Product Launches
  • Index Of Tables
    • Table 2.1: Common Immunoassay Tests
    • Table 3.1: The Overall Ivd Diagnostic Testing Market Worldwide, 2006
    • Table 3.2: Worldwide Distribution Of Ivd Testing, 2006
    • Table 3.3: Global Clinical Immunoassay Revenues, 2000 To 2012
    • Table 3.4: Worldwide Distribution Of Clinical Immunoassay Testing, 2006
    • Table 3.5: U.S. Clinical Laboratory Testing Market, 2003 To 2012
    • Table 3.6: U.S. Clinical Laboratory Diagnostic Test Market Segments, 2006
    • Table 3.7: U.S. Clinical Laboratory Diagnostic Testing Reagents And Instruments Markets By Analyte, 2006
    • Table 3.8: U.S. Clinical Immunoanalyzer Testing Market, 2000 To 2012
    • Table 3.9: European Clinical Laboratory Testing Ivd Reagents And Instruments Market (Dollars), 2000 To 2012
    • Table 3.10: European Clinical Laboratory Testing Ivd Reagents And Instruments Market (Euros), 2000 To 2012
    • Table 3.11: European Clinical Laboratory Diagnostic Reagents And Instruments Markets By Analyte, 2006
    • Table 3.12: European Clinical Laboratory Testing Diagnostics By Country Market Estimates, 2006
    • Table 3.13: The European Immunochemistry Market, 2001 To 2012
    • Table 3.14: European Immunochemical Reagents And Instruments Markets By Country, 2006
    • Table 3.15: German Clinical Laboratory Testing Diagnostics Products Market Sales, 2003 To 2012
    • Table 3.16: German Clinical Immunochemistry Testing Diagnostics Products Market Sales, 2006 To 2012
    • Table 3.17: Uk Clinical Immunochemistry Testing Diagnostics Products Market Sales, 2006 To 2012
    • Table 3.18: French Clinical Immunochemistry Testing Diagnostics Products Market Sales, 2006 To 2012
    • Table 3.19: Italian Immunochemistry Diagnostics Products Market Sales, 2006 To 2012
    • Table 3.20: Spanish Clinical Laboratory Diagnostics Products Market Sales, 2006 To 2012
    • Table 3.21: Finnish Clinical Immunoassay Products Market Sales, 2006 To 2012
    • Table 3.22: Belgium Clinical Immunoassay Products Market Sales, 2006 To 2012
    • Table 3.23: Swiss Clinical Immunoassay Products Market Sales, 2006 To 2012
    • Table 3.24: Dutch Clinical Immunoassay Products Market Sales, 2006 To 2012
    • Table 3.25: Portugese Clinical Immunoassay Products Market Sales, 2006 To 2012
    • Table 3.26: Austrian Clinical Immunoassay Products Market Sales, 2006 To 2012
    • Table 3.27: Greek Clinical Immunoassay Products Market Sales, 2006 To 2012
    • Table 3.28: Polish Clinical Immunoassay Products Market Sales, 2006 To 2012
    • Table 3.29: Romanian Clinical Immunoassay Products Market Sales, 2006 To 2012
    • Table 3.30: Indian Ivd Market, 2006 To 2012
    • Table 3.31: Number Of Automated Clinical Labs In India, 2004 To 2012
    • Table 3.32: Indian Ivd Market (By Sector), 2006
    • Table 3.33: Ivd Equipment And Reagents Market (By Company) In India, 2004 And 2005
    • Table 3.34: Japanese Clinical Immunoanalyzer Testing Market, 2000 To 2008
    • Table 3.35: Chinese Clinical Diagnostic Products Market, 2000 To 2008
    • Table 3.36: Canadian Clinical Analyzer Testing Market, 2000 To 2008
    • Table 3.37: Brazilian Clinical Immunoanalyzer Testing Market, 2000 To 2008
    • Table 3.38: Turkish Clinical Analyzer Testing Market, 2000 To 2008
    • Table 3.39: Australian Clinical Immunoanalyzer Testing Market, 2000 To 2008
    • Table 3.40: Row Clinical Immunoanalyzer Testing Market, 2000 To 2008
    • Table 3.41: Estimated Number Of Clinical Laboratories In Latin America
    • Table 3.42: Principal Marketers Of Automated Clinical Immunoanalyzer Instruments
    • Table 4.1: Samples And Sample Handling Features Of Centaur Cp
    • Table 4.2: Large Immunochemistry Analyzers
    • Table 4.3: Small- To Mid-Volume Immunoassay Analyzers
    • Table 5.1: Wireless Lan Technology Companies
    • Table 5.2: Applications For Wireless Lan Technology
    • Table 5.3: Cap And Jcaho Requirements For Customized Reporting
    • Table 6.1: Hospital Laboratory Share Of Part B Medicare Spending, 1996 To 2005
    • Table 6.2: Medicare Part B Spending Per Medicare Enrollee, 1998 To 2005
    • Table 6.3: Allowed Charges For Top 25 Clinical Laboratory Procedures, 2005
    • Table 8.1: Technology Platforms For Analyzer Detection Systems
    • Table 8.2: Medicare Billing Guidelines For Multi-Channel Immunoanalyzer Tests
  • List Of Figures
    • Figure 3.1: U.S. Revenue For Six Largest Ivd Vendors, 2005
    • Figure 3.2: U.S. Revenue Change For Six Largest Ivd Vendors, 2005
    • Figure 6.1: Part B Spending On Clinical Lab Services, 1991 To 2005